<DOC>
	<DOC>NCT01805453</DOC>
	<brief_summary>To assess the efficacy of an Angiotensin-II inhibitor (Losartan) to reduce peritumoral edema in newly diagnosed glioblastoma patients.</brief_summary>
	<brief_title>Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma</brief_title>
	<detailed_description>Multicentre, randomized (1:1), double blinded trial:- Arm A: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide ) + Losartan 50mg*2/day until the halting for any reason - Arm B: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide + Placebo 2/day until the halting for any reason.</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<mesh_term>Angiotensinogen</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>18 years or older Histologically confirmed glioblastoma (Grade 4 WHO) patients eligible for radiotherapy and concomitant Temozolomide KPS ≥ 50% Adequate hematologic, liver and renal functions Patients unable to undergo an MRI with contrast Patients without any residual tumor left on the screening MRI of both flair and contrastenhanced lesions complete surgical resection) Any prior treatment of glioblastoma including any local therapy (immunotherapy, Gliadel wafers, …..) during or after surgical resection Any ongoing treatment for high blood pressure at time of inclusion, whatever the therapeutic class of drugs Systolic blood pressure &lt;110 mmHg. relative or definite contraindication to Losartan: Pregnant or breast feeding women; Women with an intact uterus (unless amenorrhoeic for the last 24 months) not using effective means of contraception Nonaffiliation to the "sécurité sociale"</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Glioblastoma</keyword>
	<keyword>Angiotensin-II inhibitors</keyword>
	<keyword>Losartan</keyword>
	<keyword>steroids</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Edema</keyword>
	<keyword>Randomized trial</keyword>
</DOC>